Named Patient Program With Certolizumab Pegol in Adults Suffering From Rheumatoid Aarthritis (RA) (NCT03559686) | Clinical Trial Compass
NO_LONGER_AVAILABLENot Applicable
Named Patient Program With Certolizumab Pegol in Adults Suffering From Rheumatoid Aarthritis (RA)
Plain-language summary
The objective of this Named Patient Program (NPP) is to provide continued availability of Certolizumab Pegol (CZP) to adult Rheumatoid Arthritis (RA) patients who participated in the open label studies C87015 (CDP870 015), C87028 (CDP870-028) and C87051 (CDP870-051). Physicians may use the option to continue offering patients CZP treatment or to transition patients off CZP to a standard care regimen.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Exclusion criteria
. A medical history of or current active tuberculosis (TB)
. A recent (\<6 months) chest X-ray with signs consistent with TB infection
. A recent (\<6 months) positive purified protein derivative (PPD) skin test (defined as induration or 5 mm or more) and/or an indeterminate or positive QuantiFERON-TB Gold or Elispot test.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Since this named patient program for certolizumab pegol is no longer available, can you tell me if there are any currently open trials or expanded access programs for certolizumab pegol that I might still be eligible for?
2Certolizumab pegol is a biologic medication — what would be the standard approved route for me to access this treatment now that this particular program has closed?
3Given that this program was specifically for adults with rheumatoid arthritis who presumably had limited other options, does my current situation suggest I should be looking at other biologics or JAK inhibitors as alternatives?
4Since this was a named patient program rather than a traditional clinical trial, what does that tell us about how certolizumab pegol's safety and effectiveness profile was already established at the time, and how does that compare to where I am in my treatment journey?
5Are there other named patient programs or compassionate use pathways for RA treatments currently available that my care team could help me explore?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.